The latest price target for CME Group (NASDAQ:CME) was reported by Raymond James on March 10, 2025. The analyst firm set a price target for $287.00 expecting CME to rise to within 12 months (a possible 9.43% upside). 51 analyst firms have reported ratings in the last year.

The latest analyst rating for CME Group (NASDAQ:CME) was provided by Raymond James, and CME Group upgraded their outperform rating.

The last upgrade for CME Group Inc happened on March 10, 2025 when Raymond James raised their price target to $287. Raymond James previously had a market perform for CME Group Inc.

The last downgrade for CME Group Inc happened on January 6, 2025 when Citigroup changed their price target from $255 to $250 for CME Group Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CME Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CME Group was filed on March 10, 2025 so you should expect the next rating to be made available sometime around March 10, 2026.

While ratings are subjective and will change, the latest CME Group (CME) rating was a upgraded with a price target of $0.00 to $287.00. The current price CME Group (CME) is trading at is $262.28, which is within the analyst’s predicted range.